In a year and a half, Eli Lilly (NYSE: LLY) has roughly doubled in value. It is now the most valuable pharmaceutical company in the world.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and ...

The Obesity Action Coalition (OAC) is proud to announce the launch of its bias-free obesity image gallery, produced in partnership with Eli Lilly and Company, at the 2024 HLTH Conference taking place ...

As an investor in Eli Lilly stock, I'm encouraged by the company's forward thinking. Not only is management making moves to ...

Lilly Ledbetter, a legendary advocate for women's equality and a driving force behind fair pay in America, died at 86 years ...

Eli Lilly’s senior VP of information and R&D IT, Ramesh Durvasula, said Lilly will use AI and tech to transform the company.

Severe malnutrition is treated with ready-to-use therapeutic food, a paste combining peanuts, sugar, milk powder, oil, ...

I'll never forget the day I met Lilly Ledbetter for the first time. It was at a White House event in 2016 commemorating the ...

Dreams of a tuition-free college education is closer than ever for five Ripley County students. The Lilly Endowment Community ...

There's no playbook for how to be competitive in artificial intelligence (AI) as a big pharma company, but Eli Lilly (NYSE: ...

All of this means Lilly investors shouldn't panic. Even in the "worst case," Lilly's weight loss drugs have driven major revenue growth, and this is likely to continue -- whether compounders halt ...